2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide
C23H34N4O5S3 — CID 175714172
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide
2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide (PubChem CID 175714172) has the molecular formula C23H34N4O5S3 and a molecular weight of 542.75 g/mol. Its IUPAC name is 2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide.
Molecular Properties
| Compound Name | 2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide |
|---|---|
| PubChem CID | 175714172 |
| Molecular Formula | C23H34N4O5S3 |
| Molecular Weight | 542.75 g/mol |
| Exact Mass | 542.17 |
| IUPAC Name | 2-N,2-N-dimethyl-5-N-[2-[2-(2-morpholin-4-ylethyl)piperidin-1-yl]phenyl]thiophene-2,5-disulfonamide |
| SMILES | CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2ccccc2N2CCCCC2CCN2CCOCC2)s1 |
| InChI | InChI=1S/C23H34N4O5S3/c1-25(2)35(30,31)23-11-10-22(33-23)34(28,29)24-20-8-3-4-9-21(20)27-13-6-5-7-19(27)12-14-26-15-17-32-18-16-26/h3-4,8-11,19,24H,5-7,12-18H2,1-2H3 |
| InChIKey | HUTSWZOZZPAWEY-UHFFFAOYSA-N |
| XLogP | 2.88 |
| TPSA | 99.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 542.75 |
| LogP ≤ 5 | 2.88 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175714172 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.